Business
MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market
MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market Cana...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n \n \n \n MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n The launch includes GMP strain-specific full spectrum cannabis oil and inhalation cartridge products to be distributed to patients under the MediPharm Labs Beacon Medical brand.\n \n \n As of\n \n July 2023\n \n , all Australian medical cannabis products must meet strict pharmaceutical GMP standards. MediPharm Labs is one of the few companies already meeting these GMP requirements.\n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n Sept. 27, 2023\n \n \n /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that Canadian produced GMP Beacon Medical cannabis oil and inhalation cartridges have now been launched in the Australian medical market.\n \n \n \n \n \n \n \n \n \n MediPharm is uniquely positioned to service this expanding medical market as it holds an Australian GMP license from the Therapeutic Goods Administration (TGA), complemented by its GMP status from Health Canada (Drug Establishment License) and US FDA.  In\n \n July 2023\n \n , the TGA revised import and medical cannabis regulations, requiring all products to meet cGMP standards. This bans the import of products from non-GMP sources, limiting MediPharm's competition in the manufactured cannabis product segment.\n \n \n The cannabis oil portfolio is comprised of a high CBD Isolate (THC free) oil; a balanced oil and a THC dominant full spectrum oil made with Beacon's popular medical flower strains.\n \n \n The inhalation cartridges include flavour-forward options popular with patients in the Canadian market and strain-specific full spectrum cartridges that utilize flower varieties already favored by Beacon Medical patients.\n \n \n With Beacon Medical's Pink Kush and GSC products now available in flower, oil and inhalation formats, the Company provides physi...